Shubin Wang

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University · ORCID：0000-0001-6790-6745

发表论文 127 篇 · 总被引 2552 次 · h-index 25

代表论文

• Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial (2024 · Nature Medicine · 被引 36)
• Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges (2023 · BMC Cancer · 被引 33)
• Advances in Molecular Function and Recombinant Expression of Human Collagen (2025 · Pharmaceuticals · 被引 28)
• Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis (2025 · BMC Women s Health · 被引 18)
• Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology (2024 · Journal of Molecular Medicine · 被引 13)
• Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma (2024 · Genome Medicine · 被引 12)